Sionna Therapeutics Announces the Promotion of the Dual Combination of Sion-451 and Sion-2222 into Phase 2a Conceptual Verification Trials
2026-09-15 04:02:58
According to CoinMeta, Sionna Therapeutics announced plans to advance the dual combination of Sion-451 and Sion-2222 into Phase 2a of the concept validation trials.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.